# Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension

> **NCT01080768** · PHASE2 · TERMINATED · sponsor: **Novartis Pharmaceuticals** · enrollment: 31 (actual)

## Conditions studied

- Hypertension
- Ankle Edema

## Interventions

- **DRUG:** Aliskiren/amlodipine
- **DRUG:** Amlodipine
- **DRUG:** Placebo to Aliskiren/amlodipine
- **DRUG:** Placebo to Amlodipine

## Key facts

- **NCT ID:** NCT01080768
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Publication of data from a similar study made the current study redundant.
- **Last updated:** 2011-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01080768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01080768, "Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01080768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*